Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The recent introduction of routine immunisation against human papillomavirus (HPV) in adolescent girls in the UK has focused attention on the potential for immunisation in this age group. In this review the authors suggest that this is an opportunity that is not being fully utilised. In particular, there are arguments for adolescent vaccines to boost immunity against Bordetella pertussis and Neisseria meningitidis infections, and the successful implementation of the HPV vaccine could be taken as a model to prevent another sexually transmitted carcinogenic infection, hepatitis B virus.

Original publication

DOI

10.1136/adc.2010.196667

Type

Journal article

Journal

Arch Dis Child

Publication Date

05/2011

Volume

96

Pages

492 - 495

Keywords

Adolescent, Adolescent Health Services, Female, Hepatitis B, Hepatitis B Vaccines, Humans, Immunization Programs, Immunization Schedule, Male, Meningitis, Meningococcal, Papillomavirus Vaccines, Pertussis Vaccine, United Kingdom